Australia's most trusted
source of pharma news
Friday, 04 April 2025
Posted 3 April 2025 AM
The PBAC has dropped the agenda for its upcoming July meeting with 49 submissions on the table of which 14 cover innovative drugs seeking their first PBS listing.
New PBS listings dominated the first edition of the agenda at 29, followed by 14 change to existing listing submissions, and two new NIP listing submissions. The PBAC will also consider four sub-committee DUSC analyses submitted by Roche, Medison Pharma, BMS, and Biogen.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.